Please login to the form below

Not currently logged in

Bavarian Nordic

This page shows the latest Bavarian Nordic news and features for those working in and with pharma, biotech and healthcare.

GlaxoSmithKline reportedly looking to sell select antibiotic brands

GlaxoSmithKline reportedly looking to sell select antibiotic brands

The Stada deal was just the latest in a string of divestments – in January GSK signed a deal worth up to 955m with Bavarian Nordic to offload its travel vaccines Rabipur

Latest news

More from news
Approximately 4 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2015 Deal Watch December 2015

    200. Bavarian Nordic (DK). Janssen. Collaboration, licence. Vaccine platform technology for development of treatment for cancers induced by HPV.

  • The world is our laboratory The world is our laboratory

    The vaccine regimen, which was discovered in a collaborative research programme with the National Institutes of Health, combines our preventative vaccine with a vaccine from Bavarian Nordic, a biotechnology company based ... Our commitment also included

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    1, 100. Bavarian Nordic / BMS. Option to license and commercialise.

  • Pharma deals in March 2015 Pharma deals in March 2015

    Fortunately, at end 2014 Bavarian Nordic was profitable and had over $175m in cash and an R&D cost of around $85m per year. ... One of Bavarian Nordic's sites is in Martinsried, the biotech cluster near Munich.

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    Identifying new agents in asthma and COPD. 196. Bavarian Nordic/J&J. Licence and supply.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...